3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
15
Lung Neoplasms
5
Neoplasms
4
Sarcoma
3
Sarcoma, Ewing
2
Neuroendocrine Tumors
2
Desmoplastic Small Round Cell Tumor
2
Stomach Neoplasms
1
SCLC, Extensive Stage
1
Platinum-Resistant Lung Small Cell Carcinoma
1
Ovarian Neoplasms
1
Neutropenia
1
Mesothelioma
1
Leiomyosarcoma
1
Glioblastoma
1
Gastrointestinal Malignancies
1
Gastro-enteropancreatic neuroendocrine tumor
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Adenoma, Islet Cell
1
Interventions
pembrolizumab
44
Gemcitabine
23
enfortumab vedotin
21
Nivolumab
20
Cisplatin
17
avelumab
16
Magnetic Resonance Spectroscopy
15
Carboplatin
14
atezolizumab
13
Specimen Handling
12
Docetaxel
11
sacituzumab govitecan
9
Paclitaxel
8
Ipilimumab
8
durvalumab
6
Mitomycin
5
Fluorodeoxyglucose F18
5
cabozantinib
4
Taxes
4
toripalimab
3
pemigatinib
3
erdafitinib
3
X-Rays
3
Radiosurgery
3
Platinum
3
Pemetrexed
3
Immunoglobulin G
3
CTLA-4 Antigen
3
Biopsy
3
ALT-803
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
PM 01183
×
1 year
×
Clear all
No trials found.